SB
Samsara BioCapital Portfolio holdings
AUM
$766M
1-Year Est. Return
329.84%
1 Year Est. Return
+329.84%
AUM
$489M
AUM Growth
-$71.9M
(-13%)
Holding
39
Top Sells
| 1 | +$7.66M | |
| 2 | +$6.85M | |
| 3 | +$6.23M | |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
+$5.54M |
| 5 |
LENZ
LENZ Therapeutics
LENZ
|
+$5.37M |
Sector Composition
| 1 | Healthcare | 99.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARTV
26
Artiva Biotherapeutics
ARTV
$79.4M
| $440K | 0.09% |
291,666
|
|
||
27
Bolt Biotherapeutics
BOLT
$8.77M
| $303K | 0.06% |
52,456
-2
|
|
||
28
Nuvation Bio Inc Warrants
NUVB.WS
$32.5M
| $36K | 0.01% |
133,333
|
|
||
29
Surrozen Inc Warrant
SRZNW
$44.6K
| $1.81K | ﹤0.01% |
99,999
|
|
||
|
ABVX
30
Abivax
ABVX
$8.59B
| – | – |
-425,000
|
|
||
|
ALLK
31
DELISTED
Allakos
ALLK
| – | – |
-172,089
|
|
||
32
Curis
CRIS
$17.2M
| – | – |
-185,943
|
|
||
|
INZY
33
DELISTED
Inozyme Pharma
INZY
| – | – |
-1,562,500
|
|
||
|
KRON
34
DELISTED
Kronos Bio
KRON
| – | – |
-78,131
|
|
||
|
CYPH
35
Cypherpunk Technologies Inc
CYPH
$156M
| – | – |
-2,442,352
|
|
||
36
Lyra Therapeutics
LYRA
$6.33M
| – | – |
-27,803
|
|
||
37
Prime Medicine
PRME
$608M
| – | – |
-405,228
|
|
||
|
SLRN
38
DELISTED
ACELYRIN
SLRN
| – | – |
-2,523,022
|
|
||
|
OKUR
39
OnKure Therapeutics
OKUR
$42.4M
| – | – |
-824,155
|
|